Immunoglobulin G Anti-Rhesus Rho (D) Human Monoclonal (Concentrate)

Human monoclonal immunoglobulin G anti-Rhesus Rho (D) (concentrate): description and application

Immunoglobulin G anti-rhesus Rho (D) human monoclonal (concentrate), also known under the international name "Immunoglobulin G monoclonal human anti-rhesus Rho (D)", is a medicinal product from the group of immunoglobulins produced in Russia by the company Hematologist. It is used to prevent hemolytic disease of the newborn and in the treatment of a number of other diseases.

Hemolytic disease of the newborn (HDN) occurs when the baby's and mother's blood are incompatible for blood type or Rh factor. In this case, the mother's antibodies can penetrate the placenta and attack the baby's red blood cells, which leads to their destruction and the development of dangerous complications. Immunoglobulin G anti-Rhesus Rho (D) human monoclonal (concentrate) contains antibodies directed against the Rh factor and can prevent the development of TTH in newborns.

In addition, this drug can be used to treat a number of other diseases associated with a disorder of the immune system. In particular, human monoclonal immunoglobulin G anti-Rhesus Rho (D) (concentrate) can be used in immunodeficiency conditions, autoimmune diseases, as well as in organ transplantation to prevent rejection.

It is important to note that this drug should only be used under medical supervision and strictly as directed. Like all medicines, immunoglobulin G anti-Rhesus Rho (D) human monoclonal (concentrate) may cause side effects, including allergic reactions, as well as fever and the risk of infection.

In conclusion, human immunoglobulin G anti-Rhesus Rho (D) monoclonal (concentrate) is an important drug that can help prevent the development of TTH and treat a number of other diseases related to the immune system. However, its use should only be carried out under the supervision of a physician and in accordance with the individual characteristics of the patient.